CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.

Saved in:
Bibliographic Details
Title: CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
Authors: Tomaz PR; Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil., Santos JR, Issa JS, Abe TO, Gaya PV, Krieger JE, Pereira AC, Santos PC
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2015 Sep; Vol. 71 (9), pp. 1067-73. Date of Electronic Publication: 2015 Jul 08.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1041
DOI:10.1007/s00228-015-1896-x